Meds Apotek AB is a Swedish online pharmacy established in 2016 and headquartered in Hägersten, Sweden. The company provides a diverse range of products including prescription and non-prescription medications, beauty items, dietary supplements, and household goods, available through its online platform, meds.se. As of August 2026, Meds Apotek employs 49 people. In September 2025, the company went public on the Nasdaq First North Premier Growth Market, raising approximately SEK 220 million in an IPO that was heavily oversubscribed, reflecting significant interest from both Swedish and international investors. For the 12 months ending June 30, 2026, Meds Apotek reported revenue of SEK 1.08 billion, marking a year-over-year increase of 16.37%. The company has a market capitalization of around SEK 479.16 million. Meds Apotek AB is licensed to sell pharmaceuticals by the Swedish Medical Products Agency, the National Food Agency, and the eHealth Agency. Key executives include founder and CEO Björn Emil Gustaf Thorngren and independent chairman Christian W. Jansson. Notable investors in the IPO include Ahlström Invest B.V., Cicero Fonder, and Swedbank Robur.
AI-researched from public web sources, not from the exchange listing itself — may contain errors or omissions and is not a substitute for verifying independently.
Meds Apotek AB's offering is currently approved on OTHER. Meds Apotek AB is headquartered in Sweden. It is classified under Biotech.
Other IPOs DiscoverIPO tracks that share a sector, market, or underwriter with Meds Apotek AB.
Drop a live deal card into your own site — works in WordPress, Ghost, Notion, Webflow, and any self-hosted page that allows an <iframe>. It does not work in Substack or in an emailed newsletter — no email client, and Substack itself, supports arbitrary iframes. For those, use the share image or the attribution text below instead.
<iframe src="https://www.discoveripo.com/embed/meds-apotek-ab" width="100%" height="300" style="border:0;max-width:560px" loading="lazy" title="Meds Apotek AB — DiscoverIPO"></iframe>
Dark by default. For a light background, use https://www.discoveripo.com/embed/meds-apotek-ab?theme=light as the src instead.
https://www.discoveripo.com/ipo/meds-apotek-ab/opengraph-image
Meds Apotek AB IPO details — tracked by DiscoverIPO: https://www.discoveripo.com/ipo/meds-apotek-ab?utm_source=embed&utm_medium=text&utm_campaign=meds-apotek-ab
Get emailed when Meds Apotek AB's terms, price, or expected date change — no weekly noise, just this company.
Meds Apotek AB is listing on OTHER.
Meds Apotek AB is a Swedish online pharmacy established in 2016 and headquartered in Hägersten, Sweden. The company provides a diverse range of products including prescription and non-prescription medications, beauty items, dietary supplements, and household goods, available through its online platform, meds.se. As of August 2026, Meds Apotek employs 49 people. In September 2025, the company went public on the Nasdaq First North Premier Growth Market, raising approximately SEK 220 million in an IPO that was heavily oversubscribed, reflecting significant interest from both Swedish and international investors. For the 12 months ending June 30, 2026, Meds Apotek reported revenue of SEK 1.08 billion, marking a year-over-year increase of 16.37%. The company has a market capitalization of around SEK 479.16 million. Meds Apotek AB is licensed to sell pharmaceuticals by the Swedish Medical Products Agency, the National Food Agency, and the eHealth Agency. Key executives include founder and CEO Björn Emil Gustaf Thorngren and independent chairman Christian W. Jansson. Notable investors in the IPO include Ahlström Invest B.V., Cicero Fonder, and Swedbank Robur.
European Securities and Markets Authority's Prospectus Regulation register — a prospectus approval date, not a confirmed listing date. Retrieved Aug 26, 2026.
View the original filing on ESMA →Not investment advice. DiscoverIPO is an informational database. Nothing here is a recommendation to buy or sell any security, and no content should be relied on as financial advice. All figures come from public filings and exchange calendars, may be incomplete or out of date, and should be verified against the original source before you act on them.
We use analytics and marketing cookies to understand traffic and improve the site. Cookie Policy